Compare · AHCO vs HIMS
AHCO vs HIMS
Side-by-side comparison of AdaptHealth Corp. (AHCO) and Hims & Hers Health Inc. (HIMS): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both AHCO and HIMS operate in Medical/Nursing Services (Health Care), so they compete in similar markets.
- HIMS is the larger of the two at $7.60B, about 5.1x AHCO ($1.49B).
- AHCO has been more active in the news (14 items in the past 4 weeks vs 7 for HIMS).
- HIMS has more recent analyst coverage (25 ratings vs 12 for AHCO).
- Company
- AdaptHealth Corp.
- Hims & Hers Health Inc.
- Price
- -
- -
- Market cap
- $1.49B
- $7.60B
- 1M return
- -
- -
- 1Y return
- -
- -
- Industry
- Medical/Nursing Services
- Medical/Nursing Services
- Exchange
- NASDAQ
- NYSE
- IPO
- 2018
- 2019
- News (4w)
- 14
- 7
- Recent ratings
- 12
- 25
AdaptHealth Corp.
AdaptHealth Corp., together with its subsidiaries, provides home healthcare equipment, medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; home medical equipment (HME) to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME medical devices and supplies on behalf of chronically ill patients with diabetes care, wound care, urological, ostomy, and nutritional supply needs. It serves beneficiaries of Medicare, Medicaid, and commercial payors. The company is headquartered in Plymouth Meeting, Pennsylvania.
Hims & Hers Health Inc.
Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers to licensed healthcare professionals. The company offers a range of health and wellness products and services available for purchase on its websites directly by customers. It provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, as well as cosmetics and supplement products, primarily focusing on wellness, sexual health, skincare, and hair care. The company's curated non-prescription products include vitamin C, melatonin, collagen protein, biotin, and teas in the wellness category; moisturizer, fragrances, face wash, and anti-wrinkle creams in the skincare category; condoms and lubricants in the sexual health category; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care category. It also offers medical consultation services; and engages in the wholesale of non-prescription product sales to retailers. Hims & Hers Health, Inc. is based in San Francisco, California.
Latest AHCO
- AdaptHealth Corp. Announces Second Quarter 2026 Earnings Release Date and Conference Call
- AdaptHealth Corp. filed SEC Form 8-K: Regulation FD Disclosure
- Chief Commercial Officer Schuster Iii Russell E. sold $117,711 worth of shares (11,275 units at $10.44) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 125,263 units (SEC Form 4)
- SEC Form 8-K filed by AdaptHealth Corp.
- Director Williams David Solomon Iii was granted 18,999 shares, increasing direct ownership by 42% to 64,044 units (SEC Form 4)
- Director Weaver Susan T was granted 18,999 shares, increasing direct ownership by 89% to 40,345 units (SEC Form 4)
- Director Connors Terence J was granted 18,999 shares, increasing direct ownership by 25% to 95,262 units (SEC Form 4)
- Director Belinfanti Gregory was granted 18,999 shares, increasing direct ownership by 22% to 104,269 units (SEC Form 4)
- Director Coppens Bradley J was granted 18,999 shares, increasing direct ownership by 25% to 96,345 units (SEC Form 4)
- Director Lundberg Theodore B. was granted 18,999 shares, increasing direct ownership by 2% to 892,495 units (SEC Form 4)
Latest HIMS
- Hims & Hers Chief Accounting Officer, Irene Becklund, Announces Departure from the Company
- Hims & Hers Health Inc. filed SEC Form 8-K: Leadership Update
- Hims & Hers to Announce Second Quarter 2026 Financial Results on August 10, 2026
- Chief Financial Officer Okupe Oluyemi exercised 7,163 shares at a strike of $5.01 and sold $261,351 worth of shares (7,163 units at $36.49) as part of a pre-agreed trading plan (SEC Form 4)
- Hims & Hers Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits
- Chief Medical Officer Carroll Patrick Harrison sold $830,410 worth of shares (23,726 units at $35.00), decreasing direct ownership by 12% to 181,861 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi exercised 6,376 shares at a strike of $5.01 and sold $619,217 worth of shares (18,197 units at $34.03) as part of a pre-agreed trading plan, decreasing direct ownership by 4% to 284,321 units (SEC Form 4)
- Chief Financial Officer Okupe Oluyemi converted options into 71,616 shares and covered exercise/tax liability with 39,541 shares, increasing direct ownership by 12% to 296,142 units (SEC Form 4) to cover withholding tax
- Chief Medical Officer Carroll Patrick Harrison converted options into 25,926 shares and covered exercise/tax liability with 8,310 shares, increasing direct ownership by 9% to 205,587 units (SEC Form 4) (withholding tax)
- Chief Operating Officer Chi Michael covered exercise/tax liability with 47,699 shares, sold $441,850 worth of shares (14,027 units at $31.50) as part of a pre-agreed trading plan and converted options into 86,264 shares, increasing direct ownership by 6% to 432,124 units (SEC Form 4) (withholding obligation)